ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Director/PDMR Shareholding
Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that certain Directors and PDMRs have exercised options granted in May 2020 (the "Exercise") over ordinary shares in the capital of the Company ("Ordinary Shares").
The Exercise has been satisfied from existing shares held in the Elixirr International plc Employee Benefit Trust (the "EBT") and as a result there is no dilution in the equity of the Company. No Directors or PDMRs are selling any of the shares resulting from the option exercise other than in certain cases, as set out below, where the EBT has purchased Ordinary Shares in order to cover the exercise price (based on the closing mid-market price on 9 July 2024).
Following the Exercise, the EBT's beneficial holding is 732,433 Ordinary Shares representing 1.5 per cent of the issued share capital of the Company.
Full details of the Exercise are detailed in the table below.
| Director/PDMR | Position | Ordinary Shares transferred from EBT | Ordinary Shares Sold | Share Sale Price | Resultant Holding | % of total voting rights |
| Graham Busby | Chief Financial Officer | 94,000 | 7,102 | 574p | 1,461,698 | 3.1% |
| Ian Ferguson | Executive Director | 15,600 | - | - | 2,432,691 | 5.1% |
| Clare Filby | Chief Operating Officer | 172,800 | 13,055 | 574p | 658,145 | 1.4% |
| Dieter Halfar | Partner | 94,000 | 7,102 | 574p | 403,359 | 0.9% |
| Brandon Bichler | Partner | 177,858 | - | - | 820,570 | 1.7% |
| Eric Rich | Partner | 185,429 | - | - | 777,547 | 1.6% |
For further information please contact:
| Elixirr International plc Stephen Newton, CEO Graham Busby, CFO
|
|
| |||
| Public and Investor Relations contacts: investor-relations@elixirr.com
Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) Stephen Keys, Charlie Beeson (Corporate Finance) Sunila de Silva (Corporate Broking)
Investec Bank plc (Joint Broker) Carlton Nelson, Henry Reast (Corporate Broking) |
+44 (0) 20 7220 0500
+44 (0) 20 7597 4000 |
| |||
|
| | | |||
About Elixirr International plc
Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | ||||||||||||||||||||||
| a) | Name | 1. Graham Busby 2. Clare Filby 3. Ian Ferguson 4. Dieter Halfar 5. Brandon Bichler 6. Eric Rich | |||||||||||||||||||||
| 2. | Reason for the Notification | ||||||||||||||||||||||
| a) | Position/status | 1. Chief Financial Officer 2. Chief Operating Officer 3. Executive Director 4. Partner 5. Partner 6. Partner | |||||||||||||||||||||
| b) | Initial notification/Amendment | Initial Notification | |||||||||||||||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||||||||||||||
| a) | Name | Elixirr International plc | |||||||||||||||||||||
| b) | LEI | 213800MKY7OHMVAKW681 | |||||||||||||||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||||||||||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | |||||||||||||||||||||
| Identification code | GB00BLPHTX84 | ||||||||||||||||||||||
| b) | Nature of the transaction | Exercise of options over Ordinary Shares | |||||||||||||||||||||
| c) | Price(s) and volume(s) |
| |||||||||||||||||||||
| d) | Aggregated information: · Aggregated volume · Price |
As in 4c) above | |||||||||||||||||||||
| e) | Date of the transaction | 12 July 2024 | |||||||||||||||||||||
| f) | Place of the transaction | Off market transaction | |||||||||||||||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||
| a) | Name | 1. Graham Busby 2. Clare Filby 3. Dieter Halfar | ||||||||||||
| 2. | Reason for the Notification | |||||||||||||
| a) | Position/status | 1. Chief Financial Officer 2. Chief Operating Officer 3. Partner | ||||||||||||
| b) | Initial notification/Amendment | Initial Notification | ||||||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||
| a) | Name | Elixirr International plc | ||||||||||||
| b) | LEI | 213800MKY7OHMVAKW681 | ||||||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||
| a) | Description of the Financial instrument, type of instrument | Ordinary shares of 0.005p each ("Ordinary Shares") | ||||||||||||
| Identification code | GB00BLPHTX84 | |||||||||||||
| b) | Nature of the transaction | Sale of Ordinary Shares | ||||||||||||
| c) | Price(s) and volume(s) |
| ||||||||||||
| d) | Aggregated information: · Aggregated volume · Price |
As in 4c) above | ||||||||||||
| e) | Date of the transaction | 12 July 2024 | ||||||||||||
| f) | Place of the transaction | Off market transaction | ||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.